Вы находитесь на странице: 1из 2

Federal Register / Vol. 72, No.

12 / Friday, January 19, 2007 / Notices 2529

ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued


Number of Number of
Form Avg. burden
respondents responses

—Salmonella (electronic) ..................................................................................................... 53 52 3/60


—Shigella (electronic) .......................................................................................................... 53 52 3/60
Foodborne Outbreak Form ................................................................................................... 54 25 15/60
Arboviral Surveillance (ArboNet) .......................................................................................... 57 1421 4/60
Influenza:
—Influenza virus (fax, Oct–May) .......................................................................................... 8 33 10/60
—Influenza virus (fax, year round) ....................................................................................... 15 52 10/60
*** Influenza virus (Internet; Oct–May) ................................................................................. 13 33 10/60
*** Influenza virus (Internet; year round) .............................................................................. 24 52 10/60
—Influenza virus (electronic, Oct–May) ............................................................................... 9 33 5/60
—Influenza virus (electronic, year round) ............................................................................ 14 52 5/60
Influenza Annual Survey ...................................................................................................... 83 1 15/60
Influenza-like Illness (Oct–May) ........................................................................................... 824 33 15/60
Influenza-like Illness (year round) ........................................................................................ 496 52 15/60
Monthly Respiratory & Enterovirus Surveillance Report:
—Excel format (electronic) ................................................................................................... 25 12 15/60
National Respiratory & Enteric Virus Surveillance System (NREVSS) ............................... 90 52 10/60
Rabies (electronic) ................................................................................................................ 50 12 8/60
Rabies (paper) ...................................................................................................................... 3 12 15/60
Waterborne Diseases Outbreak Form ................................................................................. 57 1 20/60
Cholera and other Vibrio illnesses ....................................................................................... 450 1 20/60
Calicivirus surveillance (CaliciNet) ....................................................................................... 20 5 5/60
Listeria Case Form ............................................................................................................... 53 1 30/60

Deborah Holtzman, agency’s estimate of the burden of the the goal of strengthening the national
Reports Clearance Officer, Centers for Disease proposed collection of information; (c) capacity to monitor the HIV epidemic to
Control and Prevention. ways to enhance the quality, utility, and better direct and evaluate prevention
[FR Doc. E7–704 Filed 1–18–07; 8:45 am] clarity of the information to be efforts.
BILLING CODE 4163–18–P collected; and (d) ways to minimize the Data are collected through in-person
burden of the collection of information interviews conducted with persons
on respondents, including through the systematically selected from 25
DEPARTMENT OF HEALTH AND use of automated collection techniques Metropolitan Statistical Areas (MSAs)
HUMAN SERVICES or other forms of information throughout the United States; these 25
technology. Written comments should MSAs were chosen based on having
Centers for Disease Control and be received within 60 days of this high AIDS prevalence. Persons at risk
Prevention notice. for HIV infection to be interviewed for
[60Day–07–07AG] NHBS include men who have sex with
Proposed Project men (MSM), injecting drug users (IDU),
Proposed Data Collections Submitted National HIV Behavioral Surveillance and heterosexual persons living in
for Public Comment and System (NHBS)—New—National Center census tracts that have high HIV/AIDS
Recommendations for HIV, STD, and TB Prevention prevalence (HET). A brief screening
(NCHSTP), Centers for Disease Control interview will be used to determine
In compliance with the requirement and Prevention (CDC). eligibility for participation in the full
of Section 3506(c)(2)(A) of the survey. The data from the full survey
Paperwork Reduction Act of 1995 for Background and Brief Description
will provide estimates of behavior
opportunity for public comment on The purpose of this data collection is related to the risk of HIV and other
proposed data collection projects, the to monitor behaviors related to Human sexually transmitted diseases, prior
Centers for Disease Control and Immunodeficiency Virus (HIV) infection testing for HIV, and use of HIV
Prevention (CDC) will publish periodic among persons at high risk for infection prevention services. All persons
summaries of proposed projects. To in the United States. The primary interviewed will also be offered an HIV
request more information on the objectives of the system are to obtain test, and will participate in a pre-test
proposed projects or to obtain a copy of data from samples of persons at risk to: counseling session. No other federal
the data collection plans and (a) Describe the prevalence and trends agency systematically collects this type
instruments, call 404–639–5960 and in risk behaviors; (b) describe the of information from persons at risk for
send comments to Joan F. Karr, CDC prevalence of and trends in HIV testing HIV infection. This data will have
Acting Reports Clearance Officer, 1600 and HIV infection; (c) describe the substantial impact on prevention
Clifton Road, MS–D74, Atlanta, GA prevalence of and trends in use of HIV program development and monitoring at
30333 or send an e-mail to prevention services; (d) identify met and the local, state, and national levels.
omb@cdc.gov. unmet needs for HIV prevention CDC estimates that NHBS will
Comments are invited on: (a) Whether services in order to inform health involve, per year in each of the 25
sroberts on PROD1PC70 with NOTICES

the proposed collection of information departments, community based MSAs, eligibility screening for 50 to 200
is necessary for the proper performance organizations, community planning persons and eligibility screening plus
of the functions of the agency, including groups and other stakeholders. This the survey and HIV testing with 500
whether the information shall have project addresses the goals of CDC’s HIV eligible respondents, resulting in a total
practical utility; (b) the accuracy of the prevention strategic plan, specifically of 37,500 eligible survey respondents

VerDate Aug<31>2005 18:10 Jan 18, 2007 Jkt 211001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1
2530 Federal Register / Vol. 72, No. 12 / Friday, January 19, 2007 / Notices

and 7,500 ineligible screened persons MSM in year 1, IDU in year 2, and HET characteristics of the group.
during a 3-year period. Data collection in year 3. The type of data collected for Participation of respondents is
will rotate such that interviews will be each group will vary slightly due to voluntary and there is no cost to the
conducted among one group per year: different sampling methods and risk respondents other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS


Average
Number of
Number of burden per Total burden
Respondents responses per
respondents response (in hours)
respondent (in hours)

MSM:
Screener only ........................................................................................... 5,000 1 5/60 417
Screener, survey, and testing .................................................................. 12,500 1 65/60 13,542
IDU:
Screener only ........................................................................................... 1,250 1 5/60 104
Screener, survey, and testing .................................................................. 12,500 1 90/60 18,750
HET:
Screener only ........................................................................................... 1,250 1 5/60 104
Screener, survey, and testing .................................................................. 12,500 1 75/60 15,625

Total ................................................................................................... ........................ ........................ ........................ 48,542

Dated: January 12, 2007. Matters to be Discussed: The agenda will http://www.phppo.cdc.gov/CLIAC/
Deborah Holtzman, include a review and discussion of the default.aspx.
National Breast and Cervical Cancer Early Times and Dates: 8:30 a.m.–5 p.m.,
Reports Clearance Officer, Centers for Disease
Detection Program components; and February 14, 2007; 8:30 a.m.–3 p.m.,
Control and Prevention.
discussion and review of related policies and February 15, 2007.
[FR Doc. E7–705 Filed 1–18–07; 8:45 am] emerging issues. Place: Omni Hotel at CNN Center, 100
BILLING CODE 4163–18–P Agenda items are subject to change as CNN Center, Atlanta, Georgia 30303; Phone:
priorities dictate. (404) 659–0000, Fax: (404) 525–5050 (http://
Contact Person for More Information: www.omnihotels.com/FindAHotel/
DEPARTMENT OF HEALTH AND Debra Younginer, Executive Secretary, AtlantaCNNCenter.aspx).
HUMAN SERVICES BCCEDCAC, Division of Cancer Prevention Status: Open to the public, limited only by
and Control, National Center for Chronic the space available. The meeting room
Centers for Disease Control and Disease Prevention and Health Promotion, accommodates approximately 100 people.
CDC, 4770 Buford Highway, Mailstop K–57, Purpose: This committee is charged with
Prevention Chamblee, Georgia 30316, Telephone: 770– providing scientific and technical advice and
488–1074. guidance to the Secretary of Health and
Breast and Cervical Cancer Early The Director, Management Analysis and
Detection and Control Advisory Human Services, the Assistant Secretary for
Services Office, has been delegated the Health, and the Director, CDC, regarding the
Committee authority to sign Federal Register notices need for, and the nature of, revisions to the
pertaining to announcements of meetings and standards under which clinical laboratories
In accordance with section 10(a)(2)of other committee management activities for are regulated, the impact on medical and
the Federal Advisory Committee Act both CDC and NCEH/ATSDR. laboratory practice of proposed revisions to
(Pub. L. 92–463), the Centers for Disease Dated: January 12, 2007. the standards, and the modification of the
Control and Prevention (CDC) Edward Schultz, standards to accommodate technological
announces the aforementioned Acting Director, Management Analysis and
advances.
committee meeting: Matters to be Discussed: The agenda will
Services Office, Center for Disease Control
include updates from the CDC, the Centers
Times and Dates: 8:30 a.m.–5 p.m., and Prevention.
for Medicare & Medicaid Services, and the
February 6, 2007; 8:30 a.m.–3 p.m., February [FR Doc. E7–721 Filed 1–18–07; 8:45 am] Food and Drug Administration; discussion of
7, 2007. BILLING CODE 4163–18–P the status of the ‘‘Notice of Proposed
Place: Centers for Disease Control and Rulemaking’’ for genetic testing;
Prevention, 1600 Clifton Road, NE., Tom presentations and discussion concerning the
Harkin Global Community Center, Building DEPARTMENT OF HEALTH AND future of health laboratory practice
19, Atlanta, Georgia 30333, Telephone: 404– HUMAN SERVICES specifically focusing on simple testing in
639–1717. diverse sites; reports and discussions
Status: Open to the public, limited only by Centers for Disease Control and addressing the impact of the Morbidity and
the space available. Prevention Mortality Weekly Report (MMWR)
Purpose: The committee is charged with Publication of ‘‘Good Laboratory Practices for
advising the Secretary, Department of Health Clinical Laboratory Improvement Waived Testing Sites’’; a report from the
and Human Services, and the Director, CDC, CLIAC Workgroup on ‘‘The Impact of Rapid
Advisory Committee
regarding the early detection and control of and Molecular Tests for Infectious Disease
breast and cervical cancer. The committee In accordance with section 10(a)(2) of Agents on Public Health’’ and discussion of
makes recommendations regarding national the Federal Advisory Committee Act the workgroup’s proposals related to such;
program goals and objectives; (Pub. L. 92–463), the Centers for Disease and presentations and discussion concerning
sroberts on PROD1PC70 with NOTICES

implementation strategies; and program Control and Prevention (CDC) rapid HIV testing. Agenda items are subject
priorities including surveillance, to change as priorities dictate.
announces the following committee
epidemiologic investigations, education and Providing Oral or Written Comments: It is
training, information dissemination, meeting. the policy of CLIAC to accept written public
professional interactions and collaborations, Name: Clinical Laboratory Improvement comments and provide a brief period for oral
and policy. Advisory Committee (CLIAC). Web site: public comments whenever possible.

VerDate Aug<31>2005 18:10 Jan 18, 2007 Jkt 211001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1

Вам также может понравиться